(19)
(11) EP 4 469 034 A1

(12)

(43) Date of publication:
04.12.2024 Bulletin 2024/49

(21) Application number: 22709370.5

(22) Date of filing: 24.01.2022
(51) International Patent Classification (IPC): 
A61K 31/194(2006.01)
A61K 31/734(2006.01)
A61P 1/04(2006.01)
A61K 47/36(2006.01)
A61K 31/4172(2006.01)
A61K 36/00(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 1/04; A61K 31/734; A61K 31/194; A61K 31/4172; A61K 9/0065; A61K 47/36; A61K 9/006; A61K 36/33; A61K 36/05; A61K 36/185; A61K 36/60
 
C-Sets:
  1. A61K 36/05, A61K 2300/00;
  2. A61K 36/185, A61K 2300/00;
  3. A61K 36/60, A61K 2300/00;
  4. A61K 31/734, A61K 2300/00;
  5. A61K 31/194, A61K 2300/00;
  6. A61K 31/4172, A61K 2300/00;
  7. A61K 36/33, A61K 2300/00;

(86) International application number:
PCT/IB2022/050584
(87) International publication number:
WO 2023/139414 (27.07.2023 Gazette 2023/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • Metis Healthcare S.r.L.
    20121 Milano (IT)
  • ADVENTIA PHARMA, S.L.
    35002 Las Palmas de Gran Canaria (ES)

(72) Inventors:
  • NENZIONI, Davide
    20121 Milano (IT)
  • BARON, Giovanna
    20121 Milano (IT)

(74) Representative: Croce, Valeria et al
Jacobacci & Partners S.p.A. Via Senato, 8
20121 Milano
20121 Milano (IT)

   


(54) COMPOSITION FOR TREATING ESOPHAGEAL REFLUX